A multi-center, prospective, minimal intensity BMT trial for dyskeratosis congenita

Awardee: Agarwal Suneet

Institution: Boston Children's Hospital

Award Amount: $51,000

Funding Period: January 1, 2017 - December 31, 2017

Previous
Previous

Treatment of adult polyglucosan body disease caused by an intronic mutation in glycogen branching enzyme gene.

Next
Next

Impact on Niemann-Pick C disease of the cross-talk between the c-Abl and the TFEB signaling pathways